Myomo Reports Preliminary Second Quarter 2024 Revenues and Operating Metrics

Expects record quarterly revenues of $7.2 million to $7.4 million, an increase of 92% to 97% sequentially

Generates record pipeline additions, and authorizations and orders

BOSTON (July 8, 2024) - Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, reports preliminary revenues and operating metrics for the three months ended June 30, 2024. Read more.